Ordering
Available Variants10 mg
CHA.53706-10mg
Price
€132.00
Available – Dispatch in 14 days
25 mg
CHA.53706-25mg
Price
€262.40
Available – Dispatch in 14 days
100 mg
CHA.53706-100mg
Price
€740.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.53706-10mg | €132.00 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.53706-25mg | €262.40 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHA.53706-100mg | €740.00 |
Homopolymer
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| CAS Number | 26936-41-4 |
|---|---|
| UNSPSC Code | 41106305 |
| NACRES | NA.51 |
| MDL number | MFCD00131982 |
| Assay | ≥98% (TLC) |
| Biological source | synthetic (organic) |
| Form | lyophilized powder |
| Solubility | water: 4.80-5.20 mg/mL, clear to hazy, colorless to faintly yellow |
| Storage temp. | −20°C |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Polyinosinic acid potassium salt, with the CAS number 26936-41-4, is a synthetic polynucleotide composed of inosine monophosphate residues linked by phosphodiester bonds. This compound has been utilized in various biomedical applications, including as an immunostimulant and in the development of vaccines. The potassium salt form of polyinosinic acid is often used due to its increased solubility and stability compared to the free acid form. Research has demonstrated that polyinosinic acid potassium salt can stimulate the immune system by activating certain cell types, such as dendritic cells, and inducing the production of cytokines. As a result, this compound has been explored as a potential adjuvant in vaccine formulations to enhance immune responses and improve vaccine efficacy. Further studies are ongoing to fully elucidate the mechanisms of action and potential therapeutic applications of polyinosinic acid potassium salt.
